Basilea Pharmaceutica (PK5.STU) Q3 2026 Earnings

18AugConfirmed
Q1 2026
1.64
1.68
1.71
1.74

Details

Expected EPS
3.6467223222547247
Actual EPS
N/A
Surprise EPS
-3.65
Surprise Percent
+100%

Description

Basilea Pharmaceutica (PK5.STU) will report earnings of for Q3 2026 on August 18, 2026.

0 Comments

Share your thoughts